Investigation of Leptin, Leukemia Inhibitory Factor (LIF), and IL-6 Serum Levels in Myeloid Leukemia

Journal Title: Iranian Journal of Blood and Cancer - Year 2010, Vol 2, Issue 4

Abstract

Background: Leptin has been implicated in the differentiation and proliferation of hematopoietic cells. Leukemia inhibitory factor (LIF) may play an important role, along with Interleukin-6 (IL-6) and granulocyte colony stimulating factor (G- CSF), in the regulation of early hematopoietic stem cells. The aim of the study was to evaluate serum level of leptin, LIF, and IL-6 in myeloid leukemia patients. Materials and Methods: We investigated serum level of leptin, LIF, and IL-6 levels, body mass index, hemoglobin, and hematocrit in 30 myeloid leukemia patients (15 patients with acute and 15 with chronic myeloid leukemia) before chemotherapy, and compared the results with 15 healthy controls. Results: Leptin, LIF and IL-6 serum levels, and lipid profile in myeloied leukemic patient was significantly different from the control group (p<0.05). The relationship between leptin and BMI was statistically significant in control group, whereas in the patient group, there were no significant relationship between leptin and BMI. Conclusion: Lipid profile and leptin, LIF, and IL-6 serum levels of leukemic patients were significantly different from normal population.

Authors and Affiliations

Shaban Alizadeh, Shahab Bohloli, Ali Abedi, Seyed Hadi Mousavi, Hossein Dargahi, Behzad Jafarzadeh, Nourooz Hamrang

Keywords

Related Articles

Evaluation of the Relationship Between Factor IX Inhibitor in Hemophilia B Patients and Different Types of Therapy in the North-eastern Part of Iran

Background: Hemophilia B is a bleeding disorder with a recessive X-linked inheritance pattern, in which the infected individuals have low levels of factor IX in their plasma. Affected individuals may have bleeding episod...

Treatment of Newly Diagnosed and Relapsed Hodgkin Lymphoma in Children

Hodgkin lymphoma (HL) accounts for about 10% of all childhood cancers. Five-year survival rates with modern therapies are now approaching >90-95% as a consequence of its significant sensitivity to both chemotherapy and r...

Quality Assurance and Good Manufacturing Practice in Respect of Plasma Fractionation

The Quality centers shall build up a quality system. This comprises all activi-ties in the blood center intended to ensure that all blood and all components have a quality corresponding to the intended use. Quality Assu...

Download PDF file
  • EP ID EP376978
  • DOI -
  • Views 83
  • Downloads 0

How To Cite

Shaban Alizadeh, Shahab Bohloli, Ali Abedi, Seyed Hadi Mousavi, Hossein Dargahi, Behzad Jafarzadeh, Nourooz Hamrang (2010). Investigation of Leptin, Leukemia Inhibitory Factor (LIF), and IL-6 Serum Levels in Myeloid Leukemia. Iranian Journal of Blood and Cancer, 2(4), 95-100. https://www.europub.co.uk/articles/-A-376978